premature birth

Hologics Preterm Birth Drug Makena Receives FDA Approval

Makena, previously called Gestiva, has faced years of delays at the FDA, which issued an "approvable" letter for the drug in October 2006, but delayed further action in January 2009. The agency requested more information on the dr

hologic, holx, drug, makena, premature birth, fda, gestiva, approval, medicine, health care, trial, clinical benefit, babies, infants, kv pharma, deal, cash, payment, financial, assets

Hologic (HOLX) is down fractionally in choppy trade around the even mark, after announcing today that its drug, Makena, designed to prevent premature birth, was approved by the U.S. Food and Drug Administration, but it added that

By Stephanie Shyu
sshyu@fnno.com

Latest News from FNNO

Shares of Zions Bancorporation Rise Abov...

Shares of Zions Bancorporation (NASDAQ:ZION) traded at a new 52-week high today of $27. ...

Shares of YRC Worldwide Have Risen Above...

Shares of YRC Worldwide (NASDAQ:YRCW) traded at a new 52-week high today of $21.44. Ap ...

Shares of Crosstex Energy Rise to a New ...

Shares of Crosstex Energy (NASDAQ:XTXI) traded at a new 52-week high today of $20.50. ...

Weyerhaeuser: The Winning Streak Continu...

Weyerhaeuser (NYSE:WY) traded today at a new 52-week high of $32.67. So far today appr ...

Shares of Web.com Group Inc Rise to a Ne...

Shares of Web.com Group Inc (NASDAQ:WWWW) traded today at $22.84, breaking its 52-week ...

West Pharmaceutical Services Looks to Co...

West Pharmaceutical Services (NYSE:WST) traded today at a new 52-week high of $68.67. ...

Shares of Watsco Rise Above Previous 52-...

Watsco (NYSE:WSO) traded today at a new 52-week high of $89.10. Approximately 58,000 s ...

Watch for Continued Gains in Shares of W...

Shares of WPX Energy (NYSE:WPX) traded at a new 52-week high today of $19.84. Approxim ...

Most Popular Video News